Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 9
Submit an article Journal homepage
1,407
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2

Char LeungDeakin University, Burwood, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4215-4513
ORCID Icon
Pages 2957-2958 | Received 04 Apr 2021, Accepted 20 Apr 2021, Published online: 25 May 2021

References

  • Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–33. doi:10.1159/000324710.
  • Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 2004;25(2):61–66. doi:10.1016/j.it.2003.12.004.
  • Capasso A, Ompad DC, Vieira DL, Wilder-Smith A, Tozan Y. Incidence of Guillain-Barre Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2019;13(8):e0007622. doi:10.1371/journal.pntd.0007622.
  • Martín Arias LH, Sanz R, Sáinz M, Treceño C, Carvajal A. Guillain-Barre syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015;33(31):3773–78. doi:10.1016/j.vaccine.2015.05.013.
  • Hasan I, Saif-Ur-Rahman KM, Hayat S, Papri N, Jahan I, Azam R, Ara G, Islam Z. Guillain-Barre syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis. J Peripher Nerv Syst. 2020;25(4):335–43. doi:10.1111/jns.12419.
  • Peru suspends clinical trials of Chinese Covid vaccine. Agence France-Presse. 2020 Dec 12.
  • US FDA. Vaccines and related biological products advisory committee meeting. 2021 Feb 26. [accessed 2021 Apr 5]. https://www.fda.gov/media/146217/download.
  • Lucchese G, Kanduc D. Zika virus and autoimmunity: from microcephaly to Guillain-Barré syndrome, and beyond. Autoimmun Rev. 2016;15(8):801–08. doi:10.1016/j.autrev.2016.03.020.
  • Ledford H. US authorization of first COVID vaccine marks new phase in safety monitoring. Nat News. 2020 Dec 11;588(7838):377–78. doi:10.1038/d41586-020-03542-4.
  • Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2020;397:72–74. S0140-6736(20)32623-4. doi:10.1016/S0140-6736(20)32623-4.
  • Leung C. A lesson learnt from the emergence of Zika virus: what flaviviruses can trigger Guillain-Barre syndrome? J Med Virol. 2020;92(12):2938–45. doi:10.1002/jmv.25717.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.